{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 407774264
| IUPAC_name = 10-(1-Azabicyclo[2.2.2]octan-3-ylmethyl)phenothiazine
| image = Mequitazine structure.svg
| width = 175

<!--Clinical data-->
| tradename = Primalan
| Drugs.com = {{drugs.com|international|mequitazine}}
| pregnancy_category =
| legal_status =
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 29216-28-2
| ATC_prefix = R06
| ATC_suffix = AD07
| PubChem = 4066
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB01071
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 3926
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = Y463242LY2
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D01324

<!--Chemical data-->
| C=20 | H=22 | N=2 | S=1
| molecular_weight = 322.468 g/mol
}}

'''Mequitazine''' (trade name '''Primalan''') is an [[H1 antagonist|H<sub>1</sub> antagonist]] and [[anticholinergic]] of the [[phenothiazine]] [[chemical class]]. It is used to treat [[Allergy|allergies]] and [[rhinitis]].

==Contraindications==
Severe liver disease; premature infants or full-term neonates.

==Special precautions==
[[Pregnancy]], [[Breastfeeding|lactation]]; severe cardiovascular disorders; [[asthma]]; angle-closure [[glaucoma]], [[urinary retention]], [[Benign prostatic hyperplasia|prostatic hyperplasia]], pyloroduodenal obstruction; renal and hepatic impairment; elderly, children; [[epilepsy]]. May impair ability to drive or operate machinery.

==Adverse drug reactions==
CNS depression including slight [[Somnolence|drowsiness]] to deep sleep, lassitude, [[dizziness]], [[Ataxia|incoordination]]. [[Headache]], [[Psychomotor retardation|psychomotor impairment]] and [[Muscarinic antagonist|antimuscarinic]] effects. Rarely, [[rash]]es and [[Hypersensitivity|hypersensitivity reaction]]s, blood disorders, [[convulsion]]s, [[Perspiration|sweating]], [[myalgia]], [[Paresthesia|paraesthesias]], [[Extrapyramidal symptoms|extrapyramidal effect]]s, [[tremor]], [[confusion]], sleep and GI disturbances, [[tinnitus]], [[hypotension]], [[hair loss]]. [[Photosensitivity]], [[jaundice]].

==Drug interactions==
Enhances effects of CNS depressants e.g. [[Ethanol|alcohol]], [[barbiturate]]s, [[hypnotic]]s, [[Opioid|opioid analgesic]]s, [[anxiolytic]]s and [[antipsychotic]]s. Can mask signs of [[ototoxicity]] caused by [[aminoglycoside]]s. [[QT interval|QT]] prolongation (which can lead to [[torsades de pointes]] arrhythmia) reported with [[spiramycin]].

== See also ==
* [[Phenothiazine]]

== References ==
* {{cite journal | last1 = Ramírez Chanona | first1 = N | last2 = del Rio Navarro | first2 = BE | last3 = Pérez Martín | first3 = J | title = Efficacy of Mequitazine (Primalan) on the Relief of Symptoms of Allergic Rhinoconjunctivitis in Children. Documented clinical experience | journal = Revista Alergia Mexico | date = November–December 2005 | volume = 52 | issue = 6 | pages = 221–5 | pmid = 16568706 | language = Spanish}}
* {{cite journal | last1 = Theunissen | first1 = EL | last2 = Vermeeren | first2 = A | last3 = van Oers | first3 = AC | last4 = van Maris | first4 = I | last5 = Ramaekers | first5 = JG | title = A Dose-Ranging Study of the Effects of Mequitazine on Actual Driving, Memory and Psychomotor Performance as Compared to Dexchlorpheniramine, Cetirizine and Placebo | journal = Clinical and Experimental Allergy | date = February 2004 | volume = 34 | issue = 2 | pages = 250–8 | doi = 10.1111/j.1365-2222.2004.01874.x | pmid = 14987305}}
* {{cite journal | last1 = Nakamura | first1 = K | last2 = Yokoi | first2 = T | last3 = Kodama | first3 = T | last4 = Inoue | first4 = K | last5 = Nagashima | first5 = K | last6 = Shimada | first6 = N | last7 = Shimizu | first7 = T | last8 = Kamataki | first8 = T | title = Oxidation of Histamine H<sub>1</sub> Antagonist Mequitazine is Catalyzed by Cytochrome P450 2D6 in Human Liver Microsomes | journal = The Journal of Pharmacology and Experimental Therapeutics | date = February 1998 | volume = 284 | issue = 2 | pages = 437–42 | pmid = 9454781 | url = http://jpet.aspetjournals.org/content/jpet/284/2/437.full.pdf}}
* {{cite journal | last1 = Persi | first1 = L | last2 = Dupin | first2 = O | last3 = Arnaud | first3 = B | last4 = Trinquand | first4 = C | last5 = Michel | first5 = FB | last6 = Bousquet | first6 = J | title = Efficacy of Mequitazine in Comparison with Placebo Assessed by Ocular Challenge with Allergen in Allergic Conjunctivitis | journal = Allergy | date = April 1997 | volume = 52 | issue = 4 | pages = 451–4 | doi = 10.1111/j.1398-9995.1997.tb01028.x | pmid = 9188930 | url = http://onlinelibrary.wiley.com/doi/10.1111/j.1398-9995.1997.tb01028.x/epdf}}

{{Antihistamines}}
{{Histamine receptor modulators}}
{{Muscarinic acetylcholine receptor modulators}}
{{Tricyclics}}

[[Category:H1 receptor antagonists]]
[[Category:Muscarinic antagonists]]
[[Category:Phenothiazines]]
[[Category:Quinuclidines]]